IP Library › Granted Patent US 12,351,860
Granted Patent B2
US 12,351,860 · App. 17/992,304 · Granted Jul 8, 2025

Digital analyte analysis

Inventors: Jonathan William Larson (Chelsea, MA); Qun Zhong (Lexington, MA); Darren Roy Link (Lafayette, CA)
Assignee: Bio-Rad Laboratories, Inc.
C12Q1/6816C12Q1/6827C12Q1/686C12Q1/6883C12Q1/6886C12Q2600/172
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,351,860
App. No.
17/992,304
Granted
Jul 8, 2025
Kind
B2
Abstract

The invention generally relates to droplet based digital PCR and methods for analyzing a target nucleic acid using the same. In certain embodiments, methods of the invention involve forming sample droplets containing, on average, a single target nucleic acid, amplifying the target in the droplets, excluding droplets containing amplicon from the target and amplicon from a variant of the target, and analyzing target amplicons.

Claims (32)

1. A method for detecting a target in a sample by multiplexed digital amplification assay, the method comprising:

partitioning a sample into a plurality of compartments, wherein at least a first compartment of said plurality of compartments comprises a first nucleic acid target, a first probe of a first type of probes, and a first probe of a second type of probes,

wherein at least a second compartment of said plurality of compartments comprises a second nucleic acid target, a second probe of the first type of probes, and a second probe of the second type of probes, wherein the first type of probes is configured to bind to the first nucleic acid target, wherein the second type of probes is configured to bind to the second nucleic acid target, wherein the first type of probes comprises a first label, wherein the second type of probes comprises a second label, and wherein the first label is a first fluorophore of a first type of fluorophores and the second label is a second fluorophore of the first type of fluorophores;

amplifying the first nucleic acid target and the second nucleic acid target; and

detecting a first intensity of the first label and a second intensity of the second label,

wherein a difference in intensity between the first intensity and the second intensity is based on a first concentration of the first type of probes in the plurality of compartments and a second concentration of the second type of probes in the plurality of compartments.

2. The method of claim 1 , further comprising distinguishing the first intensity from the second intensity.

3. The method of claim 2 , further comprising determining a presence of the first nucleic acid target in the first compartment and a presence of the second nucleic acid target in the second compartment.

4. The method of claim 1 , further comprising quantifying at least one of the targets, wherein the quantifying step comprises counting compartments in the plurality of compartments positive for the first intensity of the first label or positive for the second intensity of the second label.

5. The method of claim 1 , wherein the first intensity is a first fluorescence intensity and the second intensity is a second fluorescence intensity.

6. The method of claim 1 , further comprising diluting the sample prior to the partitioning step, wherein most of the compartments comprise no more than one target nucleic acid molecule.

7. The method of claim 1 , wherein the difference in intensity between the first intensity and the second intensity is further based on the use of one or more blocking oligomers.

8. The method of claim 1 , wherein the difference in intensity between the first intensity and the second intensity is further based on a first amplification efficiency of the first nucleic acid target and a second amplification efficiency of the second nucleic acid target.

9. The method of claim 1 , wherein the difference in intensity between the first intensity and the second intensity is further based on a first concentration of a first primer that binds to the first nucleic acid target in the plurality of compartments and a second concentration of a second primer that binds to the second nucleic acid target in the plurality of compartments.

10. The method of claim 1 , wherein the first compartment further comprises a first probe of a third type of probes, wherein the third type of probes is configured to bind to the first nucleic acid target, and wherein the third type of probes comprises a third label that is different from the first label.

11. The method of claim 1 , wherein the sample comprises the first nucleic acid target, the second nucleic acid target, a plurality of probes of the first type of probes, and a plurality of probes of the second type of probes.

12. A method for detecting a target in a sample by multiplexed digital amplification assay, the method comprising:

partitioning a sample into a plurality of compartments,

wherein at least a first compartment of said plurality of compartments comprises a first nucleic acid target, a first probe of a first type of probes, and a first probe of a second type of probes, wherein at least a second compartment of said plurality of compartments comprises a second nucleic acid target, a second probe of the first type of probes, and a second probe of the second type of probes, wherein the first type of probes is configured to bind to the first nucleic acid target, wherein the second type of probes is configured to bind to the second nucleic acid target, wherein the first type of probes comprises a first label, and wherein the second type of probes comprises a second label;

amplifying the first nucleic acid target and the second nucleic acid target; and

detecting a first intensity of the first label and a second intensity of the second label, wherein the first intensity of the first label is detected by a first detection channel and the second intensity of the second label is detected by the first detection channel,

wherein a difference in intensity between the first intensity and the second intensity is based on a first concentration of the first type of probes in the plurality of compartments and a second concentration of the second type of probes in the plurality of compartments.

13. The method of claim 12 , further comprising distinguishing the first intensity from the second intensity.

14. The method of claim 13 , further comprising determining a presence of the first nucleic acid target in the first compartment and a presence of the second nucleic acid target in the second compartment.

15. The method of claim 12 , further comprising quantifying at least one of the targets, wherein the quantifying step comprises counting compartments in the plurality of compartments positive for the first intensity of the first label or positive for the second intensity of the second label.

16. The method of claim 12 , wherein the first label is a first fluorophore having a color and the second label is a second fluorophore having the color.

17. The method of claim 12 , further comprising diluting the sample prior to the partitioning step, wherein most of the compartments comprise no more than one target nucleic acid molecule.

18. The method of claim 12 , wherein the difference in intensity between the first intensity and the second intensity is further based on the use of one or more blocking oligomers.

19. The method of claim 12 , wherein the difference in intensity between the first intensity and the second intensity is further based on a first amplification efficiency of the first nucleic acid target and a second amplification efficiency of the second nucleic acid target.

20. The method of claim 12 , wherein the difference in intensity between the first intensity and the second intensity is further based on a first concentration of a first primer that binds to the first nucleic acid target in the plurality of compartments and a second concentration of a second primer that binds to the second nucleic acid target in the plurality of compartments.

21. The method of claim 12 , wherein the first compartment further comprises a first probe of a third type of probes, wherein the third type of probes is configured to bind to the first nucleic acid target, and wherein the third type of probes comprises a third label that is detectable by a second detection channel.

22. The method of claim 12 , wherein the sample comprises the first nucleic acid target, the second nucleic acid target, a plurality of probes of the first type of probes, and a plurality of probes of the second type of probes.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2023
From: LARSON, JONATHAN WILLIAM; ZHONG, QUN; LINK, DARREN ROY
To: RAINDANCE TECHNOLOGIES, INC.
Reel/Frame 063055/0523 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2023
From: RAINDANCE TECHNOLOGIES, INC.
To: BIO-RAD LABORATORIES
Reel/Frame 063055/0557 →
Continuity (10)
Continuation 17574780 · Jan 13, 2022
Continuation 15688250 · Aug 28, 2017
Continuation 15019355 · Feb 9, 2016
Continuation 13773868 · Feb 22, 2013
Continuation 13026120 · Feb 11, 2011
Provisional Application 61388937 · Oct 1, 2010
Provisional Application 61347158 · May 21, 2010
Provisional Application 61331490 · May 5, 2010
Provisional Application 61304163 · Feb 12, 2010
Related Publication 20230086845A1 · Mar 23, 2023
References Cited (84)
US 6171850B1 · Nagle et al. · 2001 [cited by applicant]
US 6323040B1 · Raz et al. · 2001 [cited by applicant]
US 6960437B2 · Enzelberger et al. · 2005 [cited by applicant]
US 7118910B2 · Unger et al. · 2006 [cited by applicant]
US 9127310B2 · Larson · 2015 [cited by applicant]
US 9222128B2 · Saxonov · 2015 [cited by applicant]
US 9222132B2 · Drmanac · 2015 [cited by applicant]
US 9366632B2 · Link · 2016 [cited by applicant]
US 9399797B2 · Hutchison · 2016 [cited by applicant]
US 9494520B2 · Link · 2016 [cited by applicant]
US 9745617B2 · Larson · 2017 [cited by applicant]
US 10166522B2 · Hindson · 2019 [cited by applicant]
US 10612081B2 · Hutchison · 2020 [cited by applicant]
US 11254968B2 · Larson · 2022 [cited by applicant]
US 12031175B2 · Larson · 2024 [cited by applicant]
US 20030083276A1 · Li et al. · 2003 [cited by applicant]
US 20040180346A1 · Anderson · 2004 [cited by applicant]
US 20050129582A1 · Breidford et al. · 2005 [cited by applicant]
US 20060032746A1 · Knott et al. · 2006 [cited by applicant]
US 20070003442A1 · Link et al. · 2007 [cited by applicant]
US 20070052781A1 · Fraden et al. · 2007 [cited by applicant]
US 20070065823A1 · Dressman et al. · 2007 [cited by applicant]
US 20070202525A1 · Quake · 2007 [cited by applicant]
US 20080003142A1 · Link et al. · 2008 [cited by applicant]
US 20080014589A1 · Link et al. · 2008 [cited by applicant]
US 20080023330A1 · Viovy et al. · 2008 [cited by applicant]
US 20080241830A1 · Vogelstein · 2008 [cited by applicant]
US 20090029478A1 · Puskas · 2009 [cited by applicant]
US 20090053719A1 · Lo et al. · 2009 [cited by applicant]
US 20090069194A1 · Ramakrishnan · 2009 [cited by applicant]
US 20090087847A1 · Lo · 2009 [cited by applicant]
US 20090239308A1 · Dube · 2009 [cited by applicant]
US 20100003687A1 · Simen et al. · 2010 [cited by applicant]
US 20100022414A1 · Link et al. · 2010 [cited by applicant]
US 20100055677A1 · Colston et al. · 2010 [cited by applicant]
US 20100069250A1 · White et al. · 2010 [cited by applicant]
US 20100105112A1 · Merton et al. · 2010 [cited by applicant]
US 20100137163A1 · Link et al. · 2010 [cited by applicant]
US 20100173394A1 · Colston et al. · 2010 [cited by applicant]
US 20100273173A1 · Hirai · 2010 [cited by applicant]
US 20100273219A1 · May et al. · 2010 [cited by applicant]
US 20100304978A1 · Robbins et al. · 2010 [cited by applicant]
US 20110159499A1 · Hindson et al. · 2011 [cited by applicant]
US 20110250597A1 · Larson et al. · 2011 [cited by applicant]
US 20120164633A1 · Laffler · 2012 [cited by applicant]
US 20120190032A1 · Ness et al. · 2012 [cited by applicant]
US 20120208724A1 · Steemers et al. · 2012 [cited by applicant]
US 20120220494A1 · Samuels et al. · 2012 [cited by applicant]
US 20120258516A1 · Schultz et al. · 2012 [cited by applicant]
US 20120288857A1 · Livak · 2012 [cited by applicant]
US 20120289414A1 · Mitra et al. · 2012 [cited by applicant]
US 20120329050A1 · Nadeau et al. · 2012 [cited by applicant]
US 20130022973A1 · Hansen et al. · 2013 [cited by applicant]
US 20130099018A1 · Miller et al. · 2013 [cited by applicant]
US 20130116130A1 · Fu et al. · 2013 [cited by applicant]
US 20130261196A1 · Diamond et al. · 2013 [cited by applicant]
US 20160194700A1 · Edwards · 2016 [cited by applicant]
US 20240002910A1 · Larson · 2024 [cited by applicant]
US 20240132939A1 · Larson · 2024 [cited by applicant]
WO 2008143646A2 · 2008 [cited by applicant]
WO 2009059430A1 · 2009 [cited by applicant]
WO 2010151776A2 · 2010 [cited by applicant]
WO 2012022976A1 · 2012 [cited by applicant]
WO 2012048341A1 · 2012 [cited by applicant]
WO 2012083225A2 · 2012 [cited by applicant]
Baker, M. Clever PCR: more genotyping, smaller volumes. Nature Methods 7:351-56 (2010). [cited by applicant]
BioRad, Droplet Digital PCR Applications Guide, Feb. 1, 2010. [cited by applicant]
Kiss et al., High-throughput quantitative polymerase chain reaction in picoliter droplets, Anal Chem 80(23):8975-81 (2008). [cited by applicant]
Vogelstein & Kinzler, Digital PCR, Proc Nat'l Acad Sci USA 3:96(16):9236-41 (1999). [cited by applicant]
Hindson, B.J., et al., “High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number” Anal. Chem. (2011) 83:8604-8610, 2011, 8604-8610. [cited by applicant]
Tewhey, 2009, Microdroplet-based PCR enrichment for larg-scale targeted sequencing, Nat Biotech 27(11):1025-1031. [cited by applicant]
Birtwell, 2020, Microparticle encoding technologies for high-throughput multiplexed suspension assays, Integ Bio 5-6 (1):345-62. [cited by applicant]
Han et al., 2001, Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules, Nat Biotech 19 (7):631-35. [cited by applicant]
Li et al., 2009, Sensitive digital quantification of DNA methylation in clinical samples, Nat Biotech 27(9):858-63. [cited by applicant]
Morgan, 2004, Cytometric bead array: a multiplexed assay platform with applications in various areas of biology, Elsevier 110(3):252-66. [cited by applicant]
Pekin et al., 2010, Droplet-based microfluidics for the quantitative detection of rare mutations, 14th Int Conf on Mini Systems for Chem and Life Sci, (1):58-60. [cited by applicant]
Reichman, 2000, Handbook of optical filters for fluorescence microscopy, Chroma Tech Corp. [cited by applicant]
Sapsford et al., 2006, Materials for fluorescence resonance energy transfer analysis: beyond traditional donor-acceptor combinations, Angew Chem Int Ed Engl 45(28):4562-89. [cited by applicant]
Yeung, 2008, Fluorescence energy transfer-labeled primers for high-performance forensic DNA profiling, Electrophoresis (29):2251-59. [cited by applicant]
Fan, 2007, Detection of aneuploidy with digital polymerase chain reaction, Anal Chem 79:75767579. [cited by applicant]
Huang, 2007, Identification of 8 foodborne pathogens by multicolor combinational probe coding technology in a single realtime PCR, Clin Chem 53(10):17418. [cited by applicant]
Kiss, 2008, High throughput quantitative polymerase chain reaction in picoliter droplets, Anal Chem 80(23):897581. [cited by applicant]
Li, 2009, Sensitive digital quantificaiton of DNA methylation in clinical samples, Nat Biotech 27(9):85863. [cited by applicant]
Sapsford, 2006, Materials for fluorescence resonance energy transfer analysis, Angew Chem Int Ed Engl 45(28):456289. [cited by applicant]